Clinical Trials Browser

Phase 1/2 × Metastatic Solid Tumors × Platinum × Clear all

NCT07272590 2025-12-09

Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors

Phase 1/2 Not yet recruiting

Other solid neoplasm

Metastatic Solid Tumors